Monoclonal antibodies against the enzymatic subunit of both pertussis and cholera toxins
- PMID: 1778307
Monoclonal antibodies against the enzymatic subunit of both pertussis and cholera toxins
Abstract
A synthetic peptide corresponding to amino acids 6-17 of the A subunit of pertussis toxin was synthesised and used for the immunization of Balb/c mice and the subsequent production of monoclonal antibodies (MAbs). This peptide contains a region of eight amino acids which is homologous to a region in the cholera toxin A subunit. The properties of two of the resultant MAbs are described. Both of the antibodies (CP7-3003F7, an IgG3 and CP7-3004G6X1, an IgG1) react in an ELISA with the peptide and with intact pertussis toxin, pertussis toxin A subunit and cholera toxin A subunit, but do not react significantly with pertussis toxin B subunit, intact cholera toxin, or cholera toxin B subunit. Competition ELISA assays in which the peptide, the intact toxins and the toxin subunits were compared with respect to their ability to inhibit the binding of the MAbs to peptide-coated ELISA plates demonstrated that only pertussis toxin A subunit was as active, on a molar basis, as the peptide. Western blot analyses of the holotoxins confirmed that both MAbs were reactive only with the toxin A subunits. The MAbs were unable to neutralize the activity of cholera toxin or pertussis toxin in a Chinese hamster ovary (CHO) cell assay. Both were also unable to neutralize either the ADP-ribosylation activity or the NAD-glycohydrolase activity of the pertussis toxin A subunit. The significance of these results with respect to the role of this conserved site in the activity of these two toxins is discussed.
Similar articles
-
Evaluation of antibodies elicited by immunization with pertussis toxin.Dev Biol Stand. 1991;73:143-50. Dev Biol Stand. 1991. PMID: 1778308
-
Protective immunogenicity of synthetic peptides selected from the amino acid sequence of Bordetella pertussis toxin subunit S1.Dev Biol Stand. 1991;73:111-20. Dev Biol Stand. 1991. PMID: 1778305
-
A quantitative analysis for the ADP-ribosylation activity of pertussis toxin: an enzymatic-HPLC coupled assay applicable to formulated whole cell and acellular pertussis vaccine products.Biologicals. 2001 Jun;29(2):81-95. doi: 10.1006/biol.2001.0280. Biologicals. 2001. PMID: 11580213
-
Bacterial ADP-ribosylating toxins: form, function, and recombinant vaccine development.Behring Inst Mitt. 1997 Feb;(98):434-41. Behring Inst Mitt. 1997. PMID: 9382767 Review.
-
Molecular engineering of cholera toxin.Adv Exp Med Biol. 1995;371B:1513-8. Adv Exp Med Biol. 1995. PMID: 7502847 Review. No abstract available.
Cited by
-
Monoclonal antibodies and toxins--a perspective on function and isotype.Toxins (Basel). 2012 Jun;4(6):430-54. doi: 10.3390/toxins4060430. Epub 2012 Jun 11. Toxins (Basel). 2012. PMID: 22822456 Free PMC article. Review.
-
Characterization and utility of two monoclonal antibodies to cholera toxin B subunit.Sci Rep. 2023 Mar 15;13(1):4305. doi: 10.1038/s41598-023-30834-2. Sci Rep. 2023. PMID: 36922604 Free PMC article.
-
Progress towards recombinant anti-infective antibodies.Recent Pat Antiinfect Drug Discov. 2009 Jan;4(1):1-17. doi: 10.2174/157489109787236319. Recent Pat Antiinfect Drug Discov. 2009. PMID: 19149692 Free PMC article. Review.